← Leaderboards

Susan S Smyth

Central Arkansas Veterans Hlthcare Sys

Google Scholar ↗PubMed ↗ORCID ↗

$13,533,937

Attributed

$14,949,853

Total exposure

16

Grants

11

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–24

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$14,949,853 · 12

VA$0 · 4

By mechanism

R01$6,437,069 · 3

P01$2,520,023 · 2

T32$2,330,586 · 1

TL1$2,219,451 · 1

K08$624,295 · 1

U01$517,798 · 1

Top collaborators

Andrew J Morris10 shared
Jing Li1 shared
Mark V Williams1 shared

Most similar at Central Arkansas Veterans Hlthcare Sys

Same institution · by research overlap

Andrew J Morris$11,108,633

Others in their field

Top investigators on “Signal Transduction”

Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
Garret A Fitzgerald · University Of Pennsylvania$66,142,222
Michael Barry Kastan · Duke University$64,512,357
Randall J Bateman · Washington University$62,939,456

Research focus

Signal TransductionAtherosclerosisGeneticCardiovascular SystemInnovationCardiovascular DiseasesSignal PathwayMolecularDiagnosisPreventMediatingResponseBlood VesselsPlayInflammatoryGrantCellsInflammationProgramsBaseHyperplasiaReagentThrombosisMouse Model

Grant awards (69)

Serum Amyloid as a Critical mediator between inflammation and thrombosis$0

I01 · FY2024 · VA

Lysophosphatidic Acid and Cardiovascular Disease Risk$0

I01 · FY2024 · VA

Lysophosphatidic Acid and Cardiovascular Disease Risk$0

I01 · FY2023 · VA

Lysophosphatidic Acid and Cardiovascular Disease Risk$0

I01 · FY2022 · VA

Lysophosphatidic Acid and Cardiovascular Disease Risk$0

I01 · FY2021 · VA

Serum Amyloid as a Critical mediator between inflammation and thrombosis$0

I01 · FY2020 · VA · contact PI

Serum Amyloid as a Critical mediator between inflammation and thrombosis$0

I01 · FY2020 · VA

NRSA Training Core$570,836

TL1 · FY2019 · TR · contact PI

FASEB SRC on Lysophospholipid and Related Mediators: From Bench to Clinic$5,861

R13 · FY2019 · CA · contact PI

NRSA Training Core$558,783

TL1 · FY2018 · TR · contact PI

Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$544,681

R01 · FY2018 · HL · contact PI

Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement$517,798

U01 · FY2018 · HL

Clinical Scholars In Cardiovascular Science$175,219

T32 · FY2018 · HL · contact PI

Adipose autotaxin: a novel link between obesity and cardiovascular disease$0

I01 · FY2018 · VA · contact PI

NRSA Training Core$548,415

TL1 · FY2017 · TR · contact PI

Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$542,107

R01 · FY2017 · HL · contact PI

Clinical Scholars In Cardiovascular Science$272,276

T32 · FY2017 · HL · contact PI

Adipose autotaxin: a novel link between obesity and cardiovascular disease$0

I01 · FY2017 · VA · contact PI

NRSA Training Core$541,417

TL1 · FY2016 · TR · contact PI

Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$533,513

R01 · FY2016 · HL · contact PI

Clinical Scholars In Cardiovascular Science$269,525

T32 · FY2016 · HL · contact PI

Adipose autotaxin: a novel link between obesity and cardiovascular disease$0

I01 · FY2016 · VA · contact PI

Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$521,134

R01 · FY2015 · HL · contact PI

Clinical Scholars In Cardiovascular Science$262,531

T32 · FY2015 · HL · contact PI

Adipose autotaxin: a novel link between obesity and cardiovascular disease$0

I01 · FY2015 · VA · contact PI

Clinical Scholars in Cardiovascular Science$256,444

T32 · FY2014 · HL · contact PI

Regulation of adipose cells by autotaxin / lysophosphatidic acid signaling$0

I01 · FY2014 · VA · contact PI

Lysolipid Signaling in Cardiovascular Disease$344,365

R01 · FY2013 · HL · contact PI

Regulation of adipose cells by autotaxin / lysophosphatidic acid signaling$0

I01 · FY2013 · VA · contact PI

Lysolipid Signaling in Cardiovascular Disease$362,160

R01 · FY2012 · HL · contact PI

Clinical Scholars in Cardiovascular Science$246,908

T32 · FY2012 · HL · contact PI

Regulation of adipose cells by autotaxin / lysophosphatidic acid signaling$0

I01 · FY2012 · VA · contact PI

Lysolipid Signaling in Cardiovascular Disease$366,255

R01 · FY2011 · HL · contact PI

Clinical Scholars in Cardiovascular Science$246,853

T32 · FY2011 · HL · contact PI

Regulation of adipose cells by autotaxin / lysophosphatidic acid signaling$0

I01 · FY2011 · VA · contact PI

The Platelet-Leukocyte Switch in Vascular Disease$388,556

P01 · FY2010 · HL · contact PI

Lysolipid Signaling in Cardiovascular Disease$366,643

R01 · FY2010 · HL · contact PI

Clinical Scholars in Cardiovascular Science$242,784

T32 · FY2010 · HL · contact PI

The Platelet-Leukocyte Switch in Vascular Disease$383,212

P01 · FY2009 · HL · contact PI

Clinical Scholars in Cardiovascular Science$240,762

T32 · FY2009 · HL · contact PI

Integrin Signaling In Vascular Cells$108,044

R01 · FY2009 · HL · contact PI

Integrin Signaling In Vascular Cells$393,639

R01 · FY2008 · HL · contact PI

The Platelet-Leukocyte Switch in Vascular Disease$363,476

P01 · FY2008 · HL · contact PI

CORE--LABORATORY ANIMAL-MOUSE CARDIOVASCULAR PATHOPHYSIOLOGY$154,476

P01 · FY2008 · AG · contact PI

Clinical Scholars in Cardiovascular Science$117,284

T32 · FY2008 · HL · contact PI

Integrin Signaling In Vascular Cells$401,673

R01 · FY2007 · HL · contact PI

The Platelet-Leukocyte Switch in Vascular Disease$358,691

P01 · FY2007 · HL · contact PI

Lysolipid Signaling in Cardovascular Disease$238,941

R01 · FY2007 · HL · contact PI

CORE--LABORATORY ANIMAL-MOUSE CARDIOVASCULAR PATHOPHYSIOLOGY$153,029

P01 · FY2007 · AG · contact PI

Integrin Signaling In Vascular Cells$69,226

R01 · FY2007 · HL · contact PI

The Platelet-Leukocyte Switch in Vascular Disease$350,299

P01 · FY2006 · HL · contact PI

Lysolipid Signaling in Cardovascular Disease$246,078

R01 · FY2006 · HL · contact PI

Integrin Signaling In Vascular Cells$239,822

R01 · FY2006 · HL · contact PI

CORE--LABORATORY ANIMAL-MOUSE CARDIOVASCULAR PATHOPHYSIOLOGY$142,914

P01 · FY2006 · AG · contact PI

Integrin Signaling In Vascular Cells$292,000

R01 · FY2005 · HL

Lysolipid Signaling in Cardovascular Disease$290,844

R01 · FY2005 · HL

CORE--LABORATORY ANIMAL-MOUSE CARDIOVASCULAR PATHOPHYSIOLOGY$123,033

P01 · FY2005 · AG

Platelet Membrane Proteins in Thrombosis$122,779

K08 · FY2005 · HL

PLATELET ACTIVATION AND INFLAMMATION WITH THE USE OF BILVAIRUDIN IN PCI$3,770

M01 · FY2005 · RR

Platelet Membrane Proteins in Thrombosis$2,160

K08 · FY2005 · HL

Lysolipid Signaling in Cardovascular Disease$290,844

R01 · FY2004 · HL

Integrin Signaling In Vascular Cells$285,100

R01 · FY2004 · HL

Diabetes, Inflammation and Vascular Disease$145,500

R21 · FY2004 · DK

Platelet Membrane Proteins in Thrombosis$124,939

K08 · FY2004 · HL

CORE--LABORATORY ANIMAL-MOUSE CARDIOVASCULAR PATHOPHYSIOLOGY$102,337

P01 · FY2004 · AG

Diabetes, Inflammation and Vascular Disease$145,500

R21 · FY2003 · DK

Platelet Membrane Proteins in Thrombosis$124,939

K08 · FY2003 · HL

Platelet Membrane Proteins in Thrombosis$124,939

K08 · FY2002 · HL

Platelet Membrane Proteins in Thrombosis$124,539

K08 · FY2001 · HL